DHA cancer screening starts at 25, 40 and 75: the Dubai numbers patients need

Early cancer detection in Dubai is a schedule problem before it is a hospital problem: cervical screening starts at 25, breast and colorectal screening at 40, and most routine colorectal screening stops at 75.

That matters for medical directors, COOs and finance teams because the first decision is simple. Put the right patient into the right pathway before symptoms appear. In Dubai, the relevant regulator is the Dubai Health Authority (DHA). In Abu Dhabi and Al Ain, it is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, operators should check Ministry of Health and Prevention (MOHAP) guidance and the local licensed provider network.

The screening schedule

The cleanest Dubai starting point is the DHA Periodic Health Screening Guideline, issued on 11 March 2024 and effective from 11 May 2024. It summarises UAE national cancer screening guidance for three common pathways.

• Breast cancer: females aged 40+ should have a mammogram every two years. Earlier screening depends on family history, inherited mutations or clinician advice.
• Cervical cancer: sexually active, symptom-free women aged 25-65 are eligible. The interval is every three years for ages 25-49 and every five years for ages 50-65.
• Colorectal cancer: males and females aged 40-75 should have a faecal immunochemical test (FIT) every two years or colonoscopy every 10 years.

Abu Dhabi’s public health material is similar on the age bands, with one operational difference to check. The Abu Dhabi Public Health Center colorectal cancer programme, under DOH, recommends screening for men and women aged 40-75. ADPHC material also lists annual FIT or colonoscopy every 10 years for ages 40-75.

What the patient actually pays

Coverage and co-payments depend on the policy, network and pre-authorisation rules. For Dubai employers, the first internal check is whether the patient is on an Essential Benefits Plan and whether the pathway falls under the BASMAH cancer support arrangements. DHA says BASMAH supports cancer and hepatitis B and C through screening, early detection and treatment coverage.

Self-pay pricing is visible enough to set a finance expectation, but operators should avoid quoting a single market price. Published UAE examples in 2026 show wide variation by facility, sedation, biopsy and consultation bundle.

• Mammogram: Mediclinic Abu Dhabi and Al Ain health package material lists mammogram add-on pricing at AED 375 for women aged 40+.
• Pap smear plus HPV test: International Modern Hospital in Dubai lists a specialist consultation package at AED 399.
• Colonoscopy: Emirates Hospitals lists a Dubai screening package at AED 4,250 including one biopsy, while Elemental lists sedated colonoscopy from AED 9,000, with a gastroenterology consultation at AED 750.

The operating rule is to request a written estimate before booking colonoscopy. The estimate should state whether sedation, histology, polyp removal, anaesthesia, facility charges and follow-up consultation are included. Those line items decide whether the final bill resembles a screening package or a diagnostic procedure.

What happens after an abnormal result

An abnormal screen should trigger a diagnostic pathway, rather than a second round of shopping for packages. For mammography, that usually means diagnostic imaging, breast ultrasound, possible MRI and biopsy if indicated. For cervical screening, abnormal cytology or HPV results can lead to colposcopy and biopsy. For FIT-positive colorectal screening, colonoscopy is the diagnostic step.

For CIOs and operations teams, the handoff is the weak point. A screening provider should record the test date, result category, recommended interval and referral outcome in the patient record. A patient aged 42 with a normal mammogram needs recall in 24 months. A patient aged 44 with a positive FIT needs a tracked colonoscopy referral, not a generic wellness reminder.

In Dubai, patients and employers should verify that the screening or oncology provider is licensed through DHA systems. Abu Dhabi patients should use DOH and ADPHC channels. Northern emirates patients should check MOHAP-licensed facilities and their insurer network before booking.

The practical close is simple. Build the recall list by age, sex, symptoms, family history and emirate. Confirm coverage with the insurer, whether Sukoon, Daman, Thiqa or another payer, before the first test. For licensed oncology providers, search the UAE Open Healthcare Directory and then verify the facility licence with the relevant regulator.